Evaluating the efficacy of rimegepant as a preventive treatment for chronic and episodic migraine: a three-month longitudinal retrospective cohort study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Assessing the Effectiveness of Rimegepant for Preventing Chronic and Episodic Migraine: A Three-Month Retrospective Cohort Analysis

  • By

  • Hamza Khan

  • Muhammad Saqib Khan

  • Sheraz Khan

  • Fang Liu

  • Quan Feng

  • Irfan Ahmad

  • Ge Tan

  • June 4, 2026

Share

Original Source(s)

Related Content